Log in  First Connection?

Pediatric TransplantArchives

Characterization of emergency department visits in pediatric patients within first year of liver transplantation: ten years experience in tertiary care center

 Published on 27/05/2026 |  Original article (Full-text)  | Elmokattaf Reem et al. | BMC Emergency Medicine 2025; 25(1): 76

Liver transplant is one of the major advances in medicine and one of the most performed surgeries in transplant. In the Kingdom of Saudi Arabia, the first liver transplant was performed in 1991. However, pediatric liver transplant didn’t start until 1997, trailed by adult living donor transplant...

The effect of fecal microbial transplantation in a pediatric patient after 28 episodes of febrile urinary tract infection

 Published on 20/05/2026 |  Original article (Full-text)  | Barbora Piteková   et al. | Pediatric Nephrology 2025; 40(10): 3085-8

Recurrent fUTIs represent a significant clinical challenge, frequently resulting in multiple hospitalizions and extensive medical interventions. Furthermore, recurrent fUTIs may lead to significant consequences such as renal scarring, arterial hypertension, and progressive CKD [1]. All of these features...

Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia

 Published on 13/05/2026 |  Original article (Full-text)  | Mengze Hu et al. | Leukemia & Lymphoma 2024; 65(12): 1801-10

This retrospective analysis evaluated the use of anti-thymocyte globulin (ATG) with or without post-transplantation cyclophosphamide (PTCy) for graft-versus-host disease (GvHD) prophylaxis in children with acute leukemia undergoing hematopoietic stem cell transplantation (HSCT). The study included 57...

Haploidentical Stem Cell Transplantation With TCR-[alpha][beta]+/CD19+ Depletion in High-risk Pediatric Leukemias: Experience From a Referral Center in Peru.

 Published on 06/05/2026 |  Original article (Full-text)  | RodriguezTorres, Jackeline C. MD et al. | Journal of Pediatric Hematology/Oncology. Volume 47(4).

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) using TCR [alpha][beta]+/CD19+ depletion provides an alternative treatment for patients with high-risk (HR) leukemias without a matched donor, especially in developing nations with limited donor registries. We present the outcomes of...